Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Schizophrenia Bulletin|June 4, 2009
Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptomsEmily G Severance, Faith B Dickerson, Raphael P Viscidi, et al.
Oral Oncology|May 1, 2007
Human papillomavirus infection and oral cancer: a case-control study in Montreal, CanadaJavier Pintos, Martin J Black, Nader Sadeghi, et al.
BMC Evolutionary Biology|March 25, 2006
Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1Charles T T Edwards, Edward C Holmes, Daniel J Wilson, et al.
Annals of Neurology|June 27, 2009
Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neuronsChristian Wüthrich, Xin Dang, Susan Westmoreland, et al.
Clinical and Vaccine Immunology : CVI|October 24, 2008
Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan populationEmily G Severance, Ioannis Bossis, Faith B Dickerson, et al.
Journal of Virology|May 14, 2005
Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancerRongcun Yang, Cosette M Wheeler, Xiaojiang Chen, et al.
Clinical and Vaccine Immunology : CVI|September 2, 2011
Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virusRaphael P Viscidi, Dana E Rollison, Vernon K Sondak, et al.
Journal of the National Cancer Institute|November 25, 2010
Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohortMahboobeh Safaeian, Koen Quint, Mark Schiffman, et al.
Clinical Immunology (Orlando, Fla.)|June 28, 2022
High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19Mirko Scordio, Federica Frasca, Letizia Santinelli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2014
Prospective study of seroreactivity to JC virus T-antigen and risk of colorectal cancers and adenomasShalaka S Hampras, Raphael P Viscidi, Kathy J Helzlsouer, et al.
Pageof 10